Systematic review and meta-analysis of randomized clinical trials appraising the impact of cilostazol after percutaneous coronary intervention
- 30 June 2008
- journal article
- review article
- Published by Elsevier BV in American Heart Journal
- Vol. 155 (6), 1081-1089
- https://doi.org/10.1016/j.ahj.2007.12.024
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- Effects of Triple Antiplatelet Therapy (Aspirin, Clopidogrel, and Cilostazol) on Platelet Aggregation and P-Selectin Expression in Patients Undergoing Coronary Artery Stent ImplantationThe American Journal of Cardiology, 2007
- Angiographic Analysis of Pattern of Late Luminal Loss in Sirolimus- and Paclitaxel-Eluting StentsThe American Journal of Cardiology, 2007
- Is Late Luminal Loss an Accurate Predictor of the Clinical Effectiveness of Drug-Eluting Stents in the Coronary Arteries?The American Journal of Cardiology, 2006
- Comparison of Two Methods to Detect Publication Bias in Meta-analysisJAMA, 2006
- Adjusted indirect comparison of intracoronary drug-eluting stents: evidence from a metaanalysis of randomized bare-metal-stent-controlled trialsInternational Journal of Cardiology, 2005
- Comparison of cilostazol and clopidogrel after successful coronary stentingThe American Journal of Cardiology, 2005
- Cilostazol, clopidogrel or ticlopidine to prevent sub-acute stent thrombosis: A meta-analysis of randomized trialsAmerican Heart Journal, 2004
- Cilostazol inhibits leukocyte integrin Mac-1, leading to a potential reduction in restenosis after coronary stent implantationJournal of the American College of Cardiology, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- CilostazolDrugs & Aging, 1999